I suppose you could say that up until roughly a month ago, I hadn't given the CBD movement, as it pertains to the beauty and wellness industry, a fair shot. I had experimented here and there with balms, lotions, sprays, and under-the-tongue strips, but nothing stuck. I was intrigued, but I didn't experience anything miraculous. Therefore, I let my CBD product stash slip to the wayside. The one product I had strangely neglected? Cannabis oil. Which is weird considering oil-filled tinctures are one of the most popular ways to imbibe right now. Leave it to me to miss the train entirely only to arrive late to the party months later. Alas, I'm here now and ready to share my newest morning ritual: a CBD-infused elixir of happiness that irons out my nerves while allowing my much-needed coffee high to do its thing. Yep, squeezing CBD oil into my morning coffee has changed my life for the better. It's not surprising considering the plethora of research correlating the compound with decreased anxiety. Let me explain.
Various studies done on CBD oils and other cannabis products around the world have come to similar conclusions about incorrect label information [24, 53, 54] and the presence of contaminants [54-57]. In the absence of a clear legal status for CBD, or agreement on common safety and quality standards, it may not be surprising that current CBD products leave something to be desired. The time has come for regulators to give CBD the attention it deserves in order to ensure that affordable, safe, and reliable CBD products are available to those who depend on them.
If CBD oil was used mainly by adult, well-informed, and reasonably healthy consumers, the impact of its widespread use would perhaps be quite acceptable and limited. However, this is not the case, as CBD is actively marketed for use by children (e.g., for Dravet syndrome, ADHD, autism), elderly people (Alzheimer’s disease, dementia, Parkinson’s disease), patients suffering from complex diseases (cancer, multiple sclerosis, chronic pain), and even pets (anxiety, appetite, sleep). Indiscriminate use of CBD may lead to various issues among these consumers. For example, CBD shows an exciting potential for treating epilepsy in children, but the long-term effects of high-dose CBD on these children’s brain functions remain unclear, while there are strong clues that the endocannabinoid system is central in the proper neuronal development of the adolescent brain . In order to halt the unchecked advertising of CBD products, health authorities in various countries have begun sending official warning letters to stop producers and sellers from making unfounded health claims [24, 25].
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.